Showing results (231-240 of 268) with videos related to
Sort By:
Pageof 27
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.American Journal of Respiratory and Critical Care Medicine|March 6, 2020
Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular RejectionElizabeth Cho, Joyce K Y Wu, Daniella Cunha Birriel, et al.Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.Organic & Biomolecular Chemistry|August 30, 2003
Syntheses and biological evaluation of vinblastine congenersMartin E Kuehne, William G Bornmann, Istvan Markó, et al.The International Journal of Biological Markers|April 18, 2013
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese populationYe Tian, Jin-le Li, Liang Hao, et al.Journal of Proteomics|November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approachPatrick Y Kim, Owen Tan, Sonya M Diakiw, et al.Cell Reports|October 5, 2022
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectoryXiaojun Yuan, Janith A Seneviratne, Shibei Du, et al.Cancer Research|April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCNChi Yan Ooi, Daniel R Carter, Bing Liu, et al.Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.Pageof 27